文献速递皮肤肿瘤

TET2调控5-羟甲基胞嘧啶参与皮肤鳞状细胞癌发生

Regulation of 5-Hydroxymethylcytosine by TET2 Contributes to Squamous Cell Carcinoma Tumorigenesis.
PubMed 文献 · J Invest Dermatol · 2021-10-23

该研究通过人类皮肤鳞状细胞癌组织芯片发现5-hmC水平较邻近皮肤全局降低,并利用小鼠K14-CreER系统证实Tet2缺失促进致癌物诱导的鳞状细胞癌,且与Tp53缺失协同驱动上皮组织自发性鳞状细胞癌。机制上Tet2缺失导致表皮5-hmC局灶改变、毛囊短暂扩增细胞基因增加及表皮分化基因减少,确立TET2为鳞状细胞癌的抑癌基因。

要点

  • 人皮肤鳞癌中5-hmC水平较邻近皮肤全局降低
  • Tet2缺失促进致癌物诱导的小鼠鳞癌并与Tp53缺失协同
  • Tet2缺失改变表皮5-hmC及毛囊与分化相关基因表达

核心结论

  • TET2通过调控5-羟甲基胞嘧啶参与表皮谱系特化并作为皮肤鳞状细胞癌的抑癌基因。

研究设计与样本

  • 构建人皮肤鳞状细胞癌组织芯片比较肿瘤与邻近皮肤的5-hmC水平。
  • 使用小鼠K14-CreER系统研究Tet2缺失在致癌物诱导及与Tp53缺失协同下的鳞癌发生。
  • 分析Tet2缺失后表皮5-hmC变化和基因表达改变。

主要发现

  • 人皮肤鳞癌组织芯片中5-hmC水平较邻近皮肤全局降低。
  • 小鼠Tet2缺失促进致癌物诱导的鳞状细胞癌。
  • Tet2缺失与Tp53缺失协同驱动上皮组织自发性鳞状细胞癌。
  • Tet2缺失后表皮5-hmC水平呈局灶改变,毛囊短暂扩增细胞基因增加而表皮分化基因减少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

DNA methylation is a key regulatory event controlling a variety of physiological processes and can have dramatic effects on gene transcription. Methylated cytosine (5-methylcytosine) can be oxidized by the TET family of enzymes to 5-hydroxymethylcytosine (5-hmC), a key intermediate in the demethylation cycle, and 5-hmC levels are reduced in malignancies such as acute myeloid leukemia and melanoma. We constructed a tissue microarray of human cutaneous squamous cell carcinoma tumors and found a global reduction in 5-hmC levels compared with that in the adjacent skin. Using a murine K14-CreER system, we have found that loss of Tet2 promotes carcinogen-induced squamous cell carcinoma and cooperates with loss of Tp53 to drive spontaneous squamous cell carcinoma tumors in epithelial tissues. Analysis of changes in 5-hmC and gene expression after loss of Tet2 in the epidermis revealed focal alterations in 5-hmC levels and an increase in hair follicle transient amplifying cell genes along with a reduction in epidermal differentiation genes. These results show a role for TET2 in epidermal lineage specification, consistent with reported roles for TET enzymes in controlling lineage commitment in hematopoietic stem cells and embryonic stem cells and establishing TET2 as a bone fide tumor suppressor in squamous cell carcinoma.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Boudra R, Woappi Y, Wang D, et al. Regulation of 5-Hydroxymethylcytosine by TET2 Contributes to Squamous Cell Carcinoma Tumorigenesis. J Invest Dermatol. 2021. PMID: 34695415. doi:10.1016/j.jid.2021.09.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。